NCT03740204View on ClinicalTrials.gov

The Role of Estrogen in the Neurobiology of Eating Disorders

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 13, 2019

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Eating DisordersHypoestrogenemia
Interventions
DRUG

17-β estradiol transdermal patches with cyclic progesterone

17-β estradiol transdermal patches (100 mcg 17-β estradiol/day) with cyclic progesterone (200 mg micronized progesterone daily for 12 days every month)

DRUG

Placebo patch and pill

Placebo patch and pill

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER